Development and validation of method for quantification of amisulpride in human plasma

Research Journal of Biotechnology

Volumn 3, Issue SPEC. ISS., 2008, Pages 235-238

  Chatterjee, B ^a   Das, A ^a   Chakraborty, U S ^a   Bhaumik, U ^a   Sengupta, P ^a   Pal, T K ^a  

^a JADAVPUR UNIVERSITY   (India)

Author keywords

Amisulpride; Human plasma; Quantification

Indexed keywords

EID: 61549139796     PISSN: 09736263     EISSN: None     Source Type: Trade Journal    
DOI: None     Document Type: Conference Paper

References (8)

1. Bergemann S., Plasma amisulpride levels in schizophrenia or schizoaffective disorder, Eur. Neuropsychology., 14, 245 (2003).
2. Jean-Pierre O., Edoardo S., Murray S., Ziprasidine and amisulpride effectively treatnagative symptoms of schizophrenia: result of a 12-week double-blind study, Int. Cli. psychopharmacology., 21, 143-151 (2006).
3. Boyer P., Lecrubier Y., Puech A.J., Treatment of negative symptoms in schizophrenia with amisulpride, Br. J. Psychiatrists., 166, 68-72 (1995).
4. Sachse J., Hartter S.,Weigmann H and Heimke C., Automated determination of amisulpride by liquid chromatography with column switching and spectrometric detection. J. Chromatogr., B., 784, 405-410 (2003)
5. Ascalone V., Ripamoni M. and Malavasi B., Stereospecific determination of amisulpride, a new benzamide derivative, in human plasma and urine by automated solid phase extraction and liquid chromatography on a chiral column application to pharmacokinetics, J. Chromatogr., B, 676, 95-105 (1996).
6. Péhoureq F., Ouariki S. and Béraud B., Rapid high-performance liquid chromatographic measurement of amisulpride in human plasma: application to manage acute intoxication. J. Chromatogr., B. 789, 101-105 (2003).
7. Guidance for Industry: Bioavailability and Bioequivalence Studies for orally Administered Drug Products- General Considerations. Rockville, MD: Center for Drug Evaluation and Research. U. S. Food and Drug Administration. (2000).
8. Shah V. P., Midha K. and Sing S., Analytical method validation: bioavailability, bioequivalence and pharmacokinetic studies. Eur J Drug Metab Pharmacokin., 16, 249-255. (1992).